Authors
Loading...
Randomized trial shows miR-30b-5p inhibits prostate cancer cell growth, suggesting its potential as a therapeutic target.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: